insights_auto
Izgledi: 72.7% optimistično·0.0% pesimistično
Otvorite analizuchevron_right
EW:NYSE
Edwards Lifesciences Corp
85,78 USD
arrow_downward
−0,81%(−0,70) 1D
85,78 USD
0,00% (0,00)
bedtimeNakon radnog vremena
Zatvoreno: 7. lis, 16:00:06 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za EW...
Otvori
86,65 USD
Najviša
87,30 USD
Najniža
85,49 USD
Trž. kap.
49,44 mlr.
Prosj. kol.
3,26 mil.
Količina
3,51 mil.
P/E omjer
49,63
52-tjed. najviša
96,29 USD
52-tjed. najniža
72,30 USD
EPS
1,73 USD
Beta
0,87
Dionice u optjecaju
576,40 mil.
Broj djelatnika
16 tis.
Otvori
86,65 USD
Najviša
87,30 USD
Najniža
85,49 USD
Trž. kap.
49,44 mlr.
Prosj. kol.
3,26 mil.
Količina
3,51 mil.
P/E omjer
49,63
52-tjed. najviša
96,29 USD
52-tjed. najniža
72,30 USD
EPS
1,73 USD
Beta
0,87
Dionice u optjecaju
576,40 mil.
Broj djelatnika
16 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
The National Law Review
·
prije 10 sati
Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
Simply Wall Street
·
prije 14 sati
Did FDA Approval Just Shift Edwards Lifesciences (EW) Investment Narrative?
Profil
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Edwards Lifesciences Corp – informacije
Glavni izvršni direktor-
Zaposlenici16 tis.
Osnovano1958
SjedišteIrvine, Kalifornija, Sjedinjene Američke Države
Sektor-
Web-lokacijaedwards.com